Статті в журналах з теми "MitoTALEN"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "MitoTALEN".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Omukai, Shiho, Shin-ich Arimura, Kinya Toriyama, and Tomohiko Kazama. "Disruption of mitochondrial open reading frame 352 partially restores pollen development in cytoplasmic male sterile rice." Plant Physiology 187, no. 1 (May 20, 2021): 236–46. http://dx.doi.org/10.1093/plphys/kiab236.
Повний текст джерелаHashimoto, Masami, Sandra R. Bacman, Susana Peralta, Marni J. Falk, Anne Chomyn, David C. Chan, Sion L. Williams, and Carlos T. Moraes. "MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases." Molecular Therapy 23, no. 10 (October 2015): 1592–99. http://dx.doi.org/10.1038/mt.2015.126.
Повний текст джерелаBacman, Sandra R., Johanna H. K. Kauppila, Claudia V. Pereira, Nadee Nissanka, Maria Miranda, Milena Pinto, Sion L. Williams, Nils-Göran Larsson, James B. Stewart, and Carlos T. Moraes. "MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation." Nature Medicine 24, no. 11 (September 24, 2018): 1696–700. http://dx.doi.org/10.1038/s41591-018-0166-8.
Повний текст джерелаBacman, Sandra R., Johanna H. K. Kauppila, Claudia V. Pereira, Nadee Nissanka, Maria Miranda, Milena Pinto, Sion L. Williams, Nils-Göran Larsson, James B. Stewart, and Carlos T. Moraes. "Author Correction: MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation." Nature Medicine 24, no. 12 (October 5, 2018): 1940. http://dx.doi.org/10.1038/s41591-018-0234-0.
Повний текст джерелаYashina, D. P., and Z. A. Afanasieva. "Experience of mitotane successful in the treatment of metastatic adrenocortical cancer." Endocrine Surgery 15, no. 4 (December 14, 2022): 12–13. http://dx.doi.org/10.14341/serg12764.
Повний текст джерелаSava, Alexandra Daniela, Tiberiu Bogdan Szekely, Cornelia Togănel, Adela Vacar, and Simona Gurzu. "Adrenocortical carcinoma: A tumor with poor answer to classic chemotherapy." Acta Marisiensis - Seria Medica 69, no. 4 (December 1, 2023): 292–94. http://dx.doi.org/10.2478/amma-2023-0039.
Повний текст джерела&NA;. "Mitotane." Reactions Weekly &NA;, no. 1385 (January 2012): 33. http://dx.doi.org/10.2165/00128415-201213850-00121.
Повний текст джерела&NA;. "Mitotane." Reactions Weekly &NA;, no. 1180 (December 2007): 28. http://dx.doi.org/10.2165/00128415-200711800-00084.
Повний текст джерела&NA;. "Mitotane." Reactions Weekly &NA;, no. 1155 (June 2007): 14. http://dx.doi.org/10.2165/00128415-200711550-00039.
Повний текст джерела&NA;. "Mitotane." Reactions Weekly &NA;, no. 1399 (April 2012): 23. http://dx.doi.org/10.2165/00128415-201213990-00084.
Повний текст джерела&NA;. "Mitotane." Reactions Weekly &NA;, no. 367 (September 1991): 10. http://dx.doi.org/10.2165/00128415-199103670-00051.
Повний текст джерела&NA;. "Mitotane." Reactions Weekly &NA;, no. 407 (June 1992): 9. http://dx.doi.org/10.2165/00128415-199204070-00032.
Повний текст джерела&NA;. "Mitotane." Reactions Weekly &NA;, no. 422 (October 1992): 10. http://dx.doi.org/10.2165/00128415-199204220-00048.
Повний текст джерелаKroiss, Matthias, Dietmar Plonné, Sabine Kendl, Diana Schirmer, Cristina L. Ronchi, Andreas Schirbel, Martina Zink, et al. "Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma." European Journal of Endocrinology 174, no. 3 (March 2016): 343–53. http://dx.doi.org/10.1530/eje-15-0946.
Повний текст джерелаTakeshita, Akira, Junko Igarashi-Migitaka, Noriyuki Koibuchi, and Yasuhiro Takeuchi. "Mitotane induces CYP3A4 expression via activation of the steroid and xenobiotic receptor." Journal of Endocrinology 216, no. 3 (November 22, 2012): 297–305. http://dx.doi.org/10.1530/joe-12-0297.
Повний текст джерелаJouinot, Anne, Bernard Royer, Etienne Chatelut, Sotheara Moeung, Guillaume Assié, Audrey Thomas-Schoemann, Jérôme Bertherat, François Goldwasser, and Benoit Blanchet. "Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study." Endocrine Connections 7, no. 12 (December 2018): 1409–14. http://dx.doi.org/10.1530/ec-18-0428.
Повний текст джерелаZatelli, Maria Chiara, Erica Gentilin, Fulvia Daffara, Federico Tagliati, Giuseppe Reimondo, Gianni Carandina, Maria Rosaria Ambrosio, Massimo Terzolo, and Ettore C. degli Uberti. "Therapeutic Concentrations of Mitotane (o,p′-DDD) Inhibit Thyrotroph Cell Viability and TSH Expression and Secretion in a Mouse Cell Line Model." Endocrinology 151, no. 6 (April 14, 2010): 2453–61. http://dx.doi.org/10.1210/en.2009-1404.
Повний текст джерелаPuglisi, Soraya, Anna Calabrese, Vittoria Basile, Filippo Ceccato, Carla Scaroni, Barbara Altieri, Silvia Della Casa, et al. "Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma." Cancers 12, no. 3 (March 20, 2020): 740. http://dx.doi.org/10.3390/cancers12030740.
Повний текст джерелаMauclère-Denost, Sophie, Sophie Leboulleux, Isabelle Borget, Angelo Paci, Jacques Young, Abir Al Ghuzlan, Desiree Deandreis, et al. "High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up." European Journal of Endocrinology 166, no. 2 (February 2012): 261–68. http://dx.doi.org/10.1530/eje-11-0557.
Повний текст джерелаvan Koetsveld, Peter M., Sara G. Creemers, Fadime Dogan, Gaston J. H. Franssen, Wouter W. de Herder, Richard A. Feelders, and Leo J. Hofland. "The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures." Journal of Clinical Endocrinology & Metabolism 105, no. 2 (October 5, 2019): 407–17. http://dx.doi.org/10.1210/clinem/dgz001.
Повний текст джерелаZhulikov, Ya A., E. I. Kovalenko, V. Yu Bohyan, M. V. Khoroshilov, M. M. Gabrava, and E. V. Artamonova. "Efficacy of EDP ± mitotane chemotherapy in the treatment of metastatic adrenocortical carcinoma. Predictive and prognostic factors of efficacy." Malignant tumours 11, no. 1 (July 26, 2021): 37–46. http://dx.doi.org/10.18027/2224-5057-2021-11-1-37-46.
Повний текст джерелаHaberbosch, Linus, Lukas Maurer, Arvid Sandforth, Charlotte Wernicke, Joachim Spranger, Knut Mai, and Reiner Jumpertz von Schwartzenberg. "Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients." Endocrine-Related Cancer 29, no. 3 (March 1, 2022): 121–28. http://dx.doi.org/10.1530/erc-21-0202.
Повний текст джерелаPuglisi, Soraya, Anna Calabrese, Vittoria Basile, Filippo Ceccato, Carla Scaroni, Chiara Simeoli, Massimo Torlontano, et al. "Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment." Journal of Clinical Medicine 8, no. 11 (November 2, 2019): 1850. http://dx.doi.org/10.3390/jcm8111850.
Повний текст джерелаBasile, Vittoria, Soraya Puglisi, Barbara Altieri, Letizia Canu, Rossella Libè, Filippo Ceccato, Felix Beuschlein, et al. "What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question." Journal of Personalized Medicine 11, no. 4 (April 4, 2021): 269. http://dx.doi.org/10.3390/jpm11040269.
Повний текст джерелаWängberg, B., A. Khorram-Manesh, S. Jansson, B. Nilsson, O. Nilsson, C. E. Jakobsson, S. Lindstedt, A. Odén, and H. Ahlman. "The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane." Endocrine-Related Cancer 17, no. 1 (March 2010): 265–72. http://dx.doi.org/10.1677/erc-09-0190.
Повний текст джерелаZhulikov, Ya A., E. I. Kovalenko, V. Yu Bokhian та E. V. Artamonova. "Сurrent options and perspectives of systemic therapy for advanced or metastatic adrenocortical cancer". Malignant tumours 11, № 3 (4 січня 2022): 36–44. http://dx.doi.org/10.18027/2224-5057-2021-11-3-36-44.
Повний текст джерелаAurora, John A., Feyza Erenler, Stephany Matta, and Ronald M. Lechan. "PCSK9 Inhibitors for the Management of Mitotane-Induced Hypercholesterolemia in Adrenocortical Carcinoma." Journal of the Endocrine Society 5, Supplement_1 (May 1, 2021): A310—A311. http://dx.doi.org/10.1210/jendso/bvab048.634.
Повний текст джерелаAltieri, Barbara, Silviu Sbiera, Sabine Herterich, Silvia De Francia, Silvia Della Casa, Anna Calabrese, Alfredo Pontecorvi, et al. "Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study." Cancers 12, no. 2 (February 4, 2020): 359. http://dx.doi.org/10.3390/cancers12020359.
Повний текст джерелаSbiera, Silviu, Ellen Leich, Gerhard Liebisch, Iuliu Sbiera, Andreas Schirbel, Laura Wiemer, Silke Matysik, et al. "Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells." Endocrinology 156, no. 11 (August 25, 2015): 3895–908. http://dx.doi.org/10.1210/en.2015-1367.
Повний текст джерелаHead, Lia, Katja Kiseljak-Vassiliades, Toshimasa J. Clark, Hilary Somerset, Jonathan King, Christopher Raeburn, Maria Albuja-Cruz, et al. "Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer." Journal of the Endocrine Society 3, no. 12 (October 11, 2019): 2295–304. http://dx.doi.org/10.1210/js.2019-00305.
Повний текст джерелаNicolia, Alessandro, Nunzia Scotti, Nunzio D’Agostino, Giovanna Festa, Lorenza Sannino, Gaetano Aufiero, Shin-ichi Arimura, and Teodoro Cardi. "Mitochondrial DNA editing in potato through mitoTALEN and mitoTALECD: molecular characterization and stability of editing events." Plant Methods 20, no. 1 (January 5, 2024). http://dx.doi.org/10.1186/s13007-023-01124-9.
Повний текст джерелаKuwabara, Kosuke, Shin-ichi Arimura, Kenta Shirasawa, and Tohru Ariizumi. "orf137 triggers cytoplasmic male sterility in tomato." Plant Physiology, February 25, 2022. http://dx.doi.org/10.1093/plphys/kiac082.
Повний текст джерелаBacman, Sandra R., Jose Domingo Barrera-Paez, Milena Pinto, Derek Van Booven, James B. Stewart, Anthony J. Griswold, and Carlos T. Moraes. "mitoTALEN Reduces the Mutant mtDNA Load in Neurons." Molecular Therapy - Nucleic Acids, February 2024, 102132. http://dx.doi.org/10.1016/j.omtn.2024.102132.
Повний текст джерелаAyabe, Hiroki, Atsushi Toyoda, Akitoshi Iwamoto, Nobuhiro Tsutsumi, and Shin-ichi Arimura. "Mitochondrial gene defects in Arabidopsis can broadly affect mitochondrial gene expression through copy number." Plant Physiology, January 27, 2023. http://dx.doi.org/10.1093/plphys/kiad024.
Повний текст джерелаBi, Chongwei, Lin Wang, Yong Fan, Baolei Yuan, Gerardo Ramos-Mandujano, Yingzi Zhang, Samhan Alsolami, et al. "Single-cell individual full-length mtDNA sequencing by iMiGseq uncovers unexpected heteroplasmy shifts in mtDNA editing." Nucleic Acids Research, March 31, 2023. http://dx.doi.org/10.1093/nar/gkad208.
Повний текст джерелаNoémie, Dehaene, Boussardon Clément, Andrey Philippe, Charif Delphine, Brandt Dennis, Gilouppe Taillefer Clémence, Nietzel Thomas, et al. "The mitochondrial orf117Sha gene desynchronizes pollen development and causes pollen abortion in the Arabidopsis Sha CMS." Journal of Experimental Botany, May 11, 2024. http://dx.doi.org/10.1093/jxb/erae214.
Повний текст джерелаGokce, Birsen Ozturk, Goknur Yorulmaz, Medine Nur Kebapci, and Elif Seray Kavak Korkmaz. "P-04 Adrenocortical carcinoma case with long-term follow-up." JCEM Case Reports 2, Supplement_1 (January 2024). http://dx.doi.org/10.1210/jcemcr/luad146.007.
Повний текст джерела"Mitotane." Reactions Weekly 1854, no. 1 (May 2021): 232. http://dx.doi.org/10.1007/s40278-021-95563-7.
Повний текст джерела"Mitotane." Reactions Weekly 1907, no. 1 (May 2022): 307. http://dx.doi.org/10.1007/s40278-022-15566-8.
Повний текст джерела"Mitotane." Reactions Weekly 1907, no. 1 (May 2022): 306. http://dx.doi.org/10.1007/s40278-022-15565-8.
Повний текст джерела"Mitotane." Reactions Weekly 1909, no. 1 (June 2022): 357. http://dx.doi.org/10.1007/s40278-022-16644-5.
Повний текст джерела"Mitotane." Reactions Weekly 1899, no. 1 (March 2022): 252. http://dx.doi.org/10.1007/s40278-022-12226-1.
Повний текст джерела"Mitotane." Reactions Weekly 1876, no. 1 (October 2021): 207. http://dx.doi.org/10.1007/s40278-021-03456-0.
Повний текст джерела"Mitotane." Reactions Weekly 1708, no. 1 (June 2018): 231. http://dx.doi.org/10.1007/s40278-018-48324-x.
Повний текст джерела"Mitotane." Reactions Weekly 1722, no. 1 (October 2018): 234. http://dx.doi.org/10.1007/s40278-018-52563-3.
Повний текст джерела"Mitotane." Reactions Weekly 1635, no. 1 (January 2017): 210. http://dx.doi.org/10.1007/s40278-017-25459-1.
Повний текст джерела"Mitotane." Reactions 194, no. 1 (March 1988): 7. http://dx.doi.org/10.1007/bf03293899.
Повний текст джерела"Mitotane." Reactions Weekly 1639, no. 1 (February 2017): 193. http://dx.doi.org/10.1007/s40278-017-26490-7.
Повний текст джерела"Mitotane." Reactions Weekly 1640, no. 1 (February 2017): 255. http://dx.doi.org/10.1007/s40278-017-26808-8.
Повний текст джерела"Mitotane." Reactions Weekly 1640, no. 1 (February 2017): 256. http://dx.doi.org/10.1007/s40278-017-26809-8.
Повний текст джерела